Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences

Rhea-AI Summary

Arcturus Therapeutics (Nasdaq: ARCT), a global leader in mRNA medicines, announced its participation in several upcoming investor and scientific conferences. These include the TIDES USA on May 16, 2024, H.C. Wainwright BioConnect on May 20, 2024, Piper Sandler Lung Investor Conference on May 23, 2024, and Goldman Sachs Healthcare Conference on June 12, 2024. These events will feature presentations and fireside chats, providing the company with opportunities to showcase its advancements in infectious disease vaccines and treatments for liver and respiratory rare diseases.

Positive

• Arcturus Therapeutics is participating in multiple high-profile conferences, enhancing its visibility and potential investor interest.
• The company will present at TIDES USA, a significant event in oligonucleotide and peptide therapeutics.
• Arcturus will engage in fireside chats at prominent investor conferences, facilitating direct communication with investors and stakeholders.

Negative

• The press release does not provide specific updates on financial performance or detailed clinical milestones.
• No new product launches or significant clinical trial results were disclosed in this announcement.
• Participating in conferences alone may not directly impact the stock price without accompanying substantial business or clinical updates.

SAN DIEGO--(BUSINESS WIRE)-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor and scientific conferences:

TIDES USA: Oligonucleotide and Peptide Therapeutics (Presentation)

• Thursday, May 16, 2024 (4:45 p.m. ET)

H.C. Wainwright 2^nd Annual BioConnect Investor Conference as NASDAQ (Fireside Chat)

• Monday, May 20, 2024 (2:30 p.m. ET)

Piper Sandler Lung Investor Conference (Fireside Chat)

• Thursday, May 23, 2024 (2:30 p.m. ET)

Goldman Sachs 45^th Annual Healthcare Conference (Fireside Chat)

• Wednesday, June 12, 2024 (2:40 p.m. ET)

About Arcturus Therapeutics

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine (Kostaive®) in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus’ pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase deficiency and cystic fibrosis, along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Arcturus’ technologies are covered by its extensive patent portfolio (over 400 patents and patent applications in the U.S., Europe, Japan, China, and other countries). For more information, visit www.ArcturusRx.com. In addition, please connect with us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240515675057/en/

IR and Media Contacts

Arcturus Therapeutics

Neda Safarzadeh

VP, Head of IR/PR/Marketing

(858) 900-2682

IR@ArcturusRx.com

Source: Arcturus Therapeutics Holdings Inc.

FAQ

What conferences will Arcturus Therapeutics attend in 2024?

Arcturus Therapeutics will attend TIDES USA on May 16, H.C. Wainwright BioConnect on May 20, Piper Sandler Lung Investor Conference on May 23, and Goldman Sachs Healthcare Conference on June 12, 2024.

What is the stock symbol for Arcturus Therapeutics?

The stock symbol for Arcturus Therapeutics is ARCT.

What topics will Arcturus Therapeutics discuss at the upcoming conferences?

Arcturus Therapeutics will discuss developments in infectious disease vaccines and treatments for liver and respiratory rare diseases.

When is the TIDES USA conference where Arcturus Therapeutics will present?

The TIDES USA conference will take place on May 16, 2024.

What kind of events will Arcturus Therapeutics participate in at these conferences?

Arcturus Therapeutics will participate in presentations and fireside chats at the upcoming conferences.

When and where is the Goldman Sachs Healthcare Conference?

The Goldman Sachs Healthcare Conference will be held on June 12, 2024.